Growth Metrics

Volitionrx (VNRX) Cash from Operations (2019 - 2025)

Volitionrx (VNRX) has disclosed Cash from Operations for 9 consecutive years, with 3630760.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Operations rose 32.61% year-over-year to 3630760.0, compared with a TTM value of 19623242.0 through Sep 2025, down 40.02%, and an annual FY2024 reading of 25893624.0, down 43.35% over the prior year.
  • Cash from Operations was 3630760.0 for Q3 2025 at Volitionrx, up from 6262689.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 6447736.0 in Q4 2023 and bottomed at 8744744.0 in Q1 2023.
  • Average Cash from Operations over 5 years is 4962092.16, with a median of 5803687.0 recorded in 2022.
  • Peak annual rise in Cash from Operations hit 211.1% in 2023, while the deepest fall reached 342.21% in 2023.
  • Year by year, Cash from Operations stood at 4409404.0 in 2021, then tumbled by 31.62% to 5803687.0 in 2022, then soared by 211.1% to 6447736.0 in 2023, then plummeted by 184.24% to 5431775.0 in 2024, then soared by 33.16% to 3630760.0 in 2025.
  • Business Quant data shows Cash from Operations for VNRX at 3630760.0 in Q3 2025, 6262689.0 in Q2 2025, and 4298018.0 in Q1 2025.